A 48-year-old woman with newly diagnosed rheumatoid arthritis (RA) and moderate disease activity (DAS28 5.2) presents for treatment initiation. She has no prior DMARD exposure. Which is the drug of choice for first-line monotherapy in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.